Tumour response stratified by ERCC1 expression was reported by ten [21], [22], [26], [31], [32], [33], [39], [41], [42] NSCLC data-sets comprising 656 patients, 328 (50%) of whom had high expression. The gene discussed is ERCC1; the disease is neoplasm.